Acute Postprandial Glycemic and Antioxidant Responses to Maqui Berry Gummies in Adults with Overweight/Obesity: A Small Within-Subject Pilot Study
6 affiliations
- 1Centro Interdisciplinario de Neurociencia de Valparaíso (CINV), Facultad de Ciencias, Universidad de Valparaíso, Valparaíso 2362905, Chile
- 2PhD Program in Health Sciences and Engineering, Facultad de Medicina, Universidad de Valparaíso, Valparaíso 2362905, Chile
- 3Centro Interdisciplinario de Investigación Biomédica e Ingeniería para la Salud-MEDING, Escuela de Kinesiología, Facultad de Medicina, Universidad de Valparaíso, Valparaíso 2362905, Chile
- 4Centro de Micro-Bioinnovación, Facultad de Farmacia, Escuela de Nutrición y Dietética, Universidad de Valparaíso, Valparaíso 2361814, Chile
- 5Instituto de Fisiología, Facultad de Ciencias, Universidad de Valparaíso, Valparaíso 2361814, Chile
- 6Instituto de Nutrición y Tecnología de los Alimentos (INTA), Universidad de Chile, Santiago 7810430, Chile
Abstract
Maqui berry is rich in anthocyanins and has attracted interest as a functional food ingredient with potential metabolic and antioxidant effects. However, little is known about its acute postprandial effects in gummy formulations or whether microencapsulation modifies sensory or biological responses. Ten adults with overweight or obesity completed three acute conditions in a fixed sequence: white bread alone (Control), white bread with unencapsulated maqui berry gummies (UMBG), and white bread with microencapsulated maqui berry gummies (MMBG). Glucose was assessed over 120 min; insulin, glucagon-like peptide-1 (GLP-1), superoxide dismutase (SOD), catalase, and total reactive antioxidant power (TRAP) were assessed at baseline and 120 min. Sensory acceptability was evaluated separately in 66 panelists. Both formulations showed generally acceptable sensory profiles. In the reported analyses, co-consumption of gummies was associated with lower glucose concentrations (p < 0.05), and total glucose AUC was lower under MMBG than under Control (p < 0.0207). Insulin at 120 min was higher under both gummy conditions (p < 0.01), and GLP-1 was higher under MMBG (p < 0.05); however, changes in GLP-1 from baseline did not differ significantly among conditions (p > 0.05). Direct comparisons of baseline-adjusted analyses in antioxidant biomarkers established a differential response among gummies formulations, with UMBG exhibiting better TRAP results with decrement of SOD activity when adjusted for the corresponding baseline value. These preliminary observations warrant further investigation. The small sample, fixed intervention sequence, and absence of a matched placebo gummy limit causal attribution. The reported findings do not establish antioxidant protection or superiority of microencapsulation and require confirmation in an adequately powered randomized trial.
Related
- Acute Postprandial Glycemic Responses to Breads Made from Five Commercial Wheat-Flour Formulations: A Small Exploratory Nonrandomized Within-Participant Crossover Study
- Ultra-processed food intake and postprandial glycemic responses in healthy Korean young adults
- Letter to the Editor: Dietary Antioxidant Minerals (Cr, Mg, Cu, Se, Zn) in Diabetic Children and their Relationship with Fasting and Postprandial Blood Glucose
- Effects of Breakfasts with Different Carbohydrate Contents and Glycemic Index Values on Postprandial Subjective Satiety and Plasma Gut Hormone Concentrations in Healthy Adults: An Exploratory Secondary Analysis of an Acute Randomized Crossover Controlled-Feeding Study
- The Lost Glucose Sink: Association of Sarcopenia Risk with Disproportionate Postprandial Glycemic Excursions in Older Adults with Type 2 Diabetes Mellitus
BibTeX
@article{acevedohernandez2026acute,
title = {{Acute Postprandial Glycemic and Antioxidant Responses to Maqui Berry Gummies in Adults with Overweight/Obesity: A Small Within-Subject Pilot Study}},
author = {Paula Acevedo-Hernández and Viviana Valero-Jara and Carlos Jara-Gutiérrez and Claudia Ibacache-Quiroga and Gonzalo Jorquera and Samanta Thomas-Valdés},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27209133},
url = {https://www.mdpi.com/1422-0067/27/20/9133},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Acute Postprandial Glycemic and Antioxidant Responses to Maqui Berry Gummies in Adults with Overweight/Obesity: A Small Within-Subject Pilot Study
AU - Paula Acevedo-Hernández
AU - Viviana Valero-Jara
AU - Carlos Jara-Gutiérrez
AU - Claudia Ibacache-Quiroga
AU - Gonzalo Jorquera
AU - Samanta Thomas-Valdés
PY - 2026
DA - 2026/10/01
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27209133
UR - https://www.mdpi.com/1422-0067/27/20/9133
AB - Maqui berry is rich in anthocyanins and has attracted interest as a functional food ingredient with potential metabolic and antioxidant effects. However, little is known about its acute postprandial effects in gummy formulations or whether microencapsulation modifies sensory or biological responses. Ten adults with overweight or obesity completed three acute conditions in a fixed sequence: white bread alone (Control), white bread with unencapsulated maqui berry gummies (UMBG), and white bread with microencapsulated maqui berry gummies (MMBG). Glucose was assessed over 120 min; insulin, glucagon-like peptide-1 (GLP-1), superoxide dismutase (SOD), catalase, and total reactive antioxidant power (TRAP) were assessed at baseline and 120 min. Sensory acceptability was evaluated separately in 66 panelists. Both formulations showed generally acceptable sensory profiles. In the reported analyses, co-consumption of gummies was associated with lower glucose concentrations (p < 0.05), and total glucose AUC was lower under MMBG than under Control (p < 0.0207). Insulin at 120 min was higher under both gummy conditions (p < 0.01), and GLP-1 was higher under MMBG (p < 0.05); however, changes in GLP-1 from baseline did not differ significantly among conditions (p > 0.05). Direct comparisons of baseline-adjusted analyses in antioxidant biomarkers established a differential response among gummies formulations, with UMBG exhibiting better TRAP results with decrement of SOD activity when adjusted for the corresponding baseline value. These preliminary observations warrant further investigation. The small sample, fixed intervention sequence, and absence of a matched placebo gummy limit causal attribution. The reported findings do not establish antioxidant protection or superiority of microencapsulation and require confirmation in an adequately powered randomized trial.
SN - 1422-0067
ER -